CTS embraces a company-wide operational excellence initiative designed to change the culture to enhance operations and the service CTS provides to its healthcare partners. As a result of this initiative, CTS teams significantly improved performance in reporting test results on time and increased efficiency by over 10 percent.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).